Meeting
2023 ASCO Genitourinary Cancers Symposium
Impact of MRI and targeted biopsy on oncological outcomes of prostate cancer after treatment.
Authors
Neha Debnath
Icahn School of Medicine at Mount Sinai Morningside/West, New York, NY
Neha Debnath , Shima Tayebi , Juliana Tobler , Sadhna Verma , Abhinav Sidana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 323)
DOI
10.1200/JCO.2023.41.6_suppl.323
Abstract #
323
Poster Bd #
L1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
18F-PSMA1007 PET/CT in the context of biochemical recurrence of prostate cancer: An economical experience from a Latin American reference center.
First Author: Maria Paula Mogollon
Poster
2019 Genitourinary Cancers Symposium
Predictors of prostate bed nodule on MRI in patients with rising PSA after radical prostatectomy.
First Author: Nicola Joseph Nasser
Poster
2019 Genitourinary Cancers Symposium
Predictors of positive lesions in 18F-fluciclovine PET/CT.
First Author: Helen Y Hougen
Poster
2017 Genitourinary Cancers Symposium
Validation of a 17-Gene Genomic Prostate Score (GPS) as a predictor of biochemical recurrence (BCR) in men with prostate cancer treated with radical prostatectomy (RP) in a community setting.
First Author: Stephen K. VanDenEeden